ATE137968T1 - Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen - Google Patents
Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionenInfo
- Publication number
- ATE137968T1 ATE137968T1 AT92115046T AT92115046T ATE137968T1 AT E137968 T1 ATE137968 T1 AT E137968T1 AT 92115046 T AT92115046 T AT 92115046T AT 92115046 T AT92115046 T AT 92115046T AT E137968 T1 ATE137968 T1 AT E137968T1
- Authority
- AT
- Austria
- Prior art keywords
- oxothiazolidine
- carboxylate
- treatment
- production
- medicinal product
- Prior art date
Links
- BMLMGCPTLHPWPY-REOHCLBHSA-N (4R)-2-oxo-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSC(=O)N1 BMLMGCPTLHPWPY-REOHCLBHSA-N 0.000 title abstract 2
- 208000031886 HIV Infections Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 230000007733 viral latency Effects 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000009117 preventive therapy Methods 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 230000007419 viral reactivation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76919491A | 1991-09-30 | 1991-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE137968T1 true ATE137968T1 (de) | 1996-06-15 |
Family
ID=25084740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92115046T ATE137968T1 (de) | 1991-09-30 | 1992-09-03 | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0535390B1 (de) |
| JP (1) | JPH05194269A (de) |
| AT (1) | ATE137968T1 (de) |
| AU (1) | AU655835B2 (de) |
| CA (1) | CA2077966A1 (de) |
| DE (1) | DE69210737T2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6060694A (en) * | 1993-05-10 | 1994-11-17 | Transcend Therapeutics, Inc | Method for treating acquired immune deficiency syndrome |
| JP4578578B2 (ja) * | 1997-01-13 | 2010-11-10 | エモリー、ユニバーシティ | インフルエンザ感染の治療用化合物及びそれらの組み合わせ |
| EP2170369B1 (de) * | 2007-06-08 | 2012-05-23 | Universiteit Gent | Viruslatenzmodell |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
| US5214062A (en) * | 1992-04-08 | 1993-05-25 | Clintec Nutrition Co. | Method and composition for treating immune disorders, inflammation and chronic infections |
| AU661379B2 (en) * | 1992-04-23 | 1995-07-20 | Transcend Therapeutics, Inc | Method of reducing or preventing toxicity associated with antiretroviral therapy |
-
1992
- 1992-09-03 AT AT92115046T patent/ATE137968T1/de not_active IP Right Cessation
- 1992-09-03 DE DE69210737T patent/DE69210737T2/de not_active Expired - Fee Related
- 1992-09-03 EP EP92115046A patent/EP0535390B1/de not_active Expired - Lifetime
- 1992-09-04 AU AU22115/92A patent/AU655835B2/en not_active Ceased
- 1992-09-10 CA CA002077966A patent/CA2077966A1/en not_active Abandoned
- 1992-09-30 JP JP4261831A patent/JPH05194269A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0535390A1 (de) | 1993-04-07 |
| AU655835B2 (en) | 1995-01-12 |
| CA2077966A1 (en) | 1993-03-31 |
| DE69210737T2 (de) | 1996-10-02 |
| JPH05194269A (ja) | 1993-08-03 |
| DE69210737D1 (de) | 1996-06-20 |
| EP0535390B1 (de) | 1996-05-15 |
| AU2211592A (en) | 1993-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE232393T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung | |
| ATE73663T1 (de) | Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ATE227587T1 (de) | Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts | |
| DE69528751D1 (de) | Verwendung von Interferon-alpha 8 subtype zur Herstellung von Medikamenten zur Behandlung von Viralinfektionen der Leber | |
| SE8704298D0 (sv) | Compounds for use in therapy | |
| DE69535758D1 (de) | Lipid-analoge zur behandlung von viralen infektionen | |
| DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| ATE170075T1 (de) | Antivirales arzneimittel enthaltend prostratin | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| ATE135223T1 (de) | Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose | |
| DK0406745T3 (da) | Antibiotiske GE 2270 faktorer A1, A2, A3 og H | |
| DE69004451D1 (de) | Prophylaxe und Behandlung von Herpesvirus-Infektionen. | |
| DK0451486T3 (da) | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T | |
| ATE137968T1 (de) | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen | |
| KR890003373A (ko) | 수면장애 및 우울증 치료에 화합물의 이용 | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| KR950702838A (ko) | 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| ATE174507T1 (de) | Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen | |
| DE69932741D1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| DE59107405D1 (de) | Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |